Improved long-term survival in all Sanz risk patients of newly diagnosed acute promyelocytic leukemia treated with a combination of retinoic acid and arsenic trioxide-based front-line therapy

Author:

Lou Yinjun1ORCID,Lu Ying2,Zhu Zhijuan13,Ma Yafang1,Suo Shanshan1,Wang Yungui1,Chen Dong2,Tong Hongyan1,Qian Wenbin1,Meng Haitao1,Mai Wenyuan1,Yu Wenjun1,Xu Weilai1,Wang Lei1,Mao Liping1,Pei Renzhi2,Jin Jie1

Affiliation:

1. Department of Hematology, Leukemia center; The First Affiliated Hospital of Zhejiang University, College of Medicine; Key Laboratory of Hematopoietic Malignancies in Zhejiang Province; Hangzhou Zhejiang People's Republic of China

2. Department of Hematology; the Ningbo Yinzhou People's Hospital; Zhejiang People's Republic of China

3. Fujian Provincial Key Laboratory of Hematology, Fujian Institute of Hematology; Fujian Medical University Union Hospital; Fuzhou Fujian People's Republic of China

Funder

Medical and Health Science Project of Zhejiang Province

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3